【2024年】おすすめの新しいオンラインカジノランキング！メリット ...

Corporate Corporate Basic Information Message from the President Corporate Profile / Access ∟Mitsubishi Chemical Group Corporation ∟Mitsubishi Chemical Corporation ∟Mitsubishi Tanabe Pharma Corporation ∟Nippon Sanso Holdings Corporation Leadership Organization Chart Global Network Number of Subsidiaries History Corporate Brochure Evaluation by Outside Parties Approach to Corporate Activities Group Concept Charter of Corporate Behavior Value Creation Model Health and Productivity Management Management Strategy Management Policy Business Strategy ∟Specialty Materials ∟Industrial Gases ∟Health Care ∟MMA ∟Petrochemicals and Carbon Products Governance Corporate Governance ∟Corporate Governance Guidelines Risk Management Compliance Media KAITEKI Solution Center  Digital Showroom  Social Media ∟LinkedIn account  ∟X account  ∟YouTube channel  Products Innovation Innovation CTO Message --> Innovation Strategy Intellectual Property Strategy Mitsubishi Chemical Corporation R&D Main R&D Organization Award History Paper Submission Investors Investors Management Policy Message from the President --> Management Policy Disclosure Policy IR News IR News TSE Filings Basic Information Chart IR Calendar Financial Data ∟Financial Highlight ∟Historical DATA  Evaluation by Outside Parties (ESG) Other IR Information ∟FAQ on IR ∟Contact on IR ∟IR Sitemap IR library Financial Results Operating Summaries Analysts Meeting Materials Integrated Reports Securities Reports Report in Line with the Recommendations of the TCFD To Our Individual Investors The Mitsubishi Chemical Group in Numbers Stock and Bond Information ∟Stock Information ∟Dividend ∟Shareholders Meeting ∟Articles of Incorporation ∟Ratings and Bonds Sustainability Sustainability Sustainability Activities Sustainability Approach and Promotion Structure Material Issues and　Sustainability(MOS) Indices​ ESG Initiatives Environment Social Governance Sustainability Data Sustainability (MOS) Results Non-Financial Data Sheets GRI Standards Integrated report "KAITEKI Report" News News Releases Information IR News TSE Filings Contact Us 日本語 English 中文 --> --> --> --> HOME News Releases 2022 News Releases 2022 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Dec. 23, 2022 Business For Treatment of ALS, Edaravone RADICUT® Oral Suspension 2.1% Approved in Japan Dec. 21, 2022 Business Withdrawal from the Acrylic Fiber Vonnel and Vonnel M.V.P Business Dec. 20, 2022 Business Notice on Cessation of the Production of Methacrylates in Mitsubishi Chemical UK Limited Dec. 19, 2022 Business Mitsubishi Chemical Group and Plug and Play Japan Announce TANAMIN Digital Health Challenge Startup Participants Dec. 16, 2022 Business Mitsubishi Chemical Group Selected for Dow Jones Sustainability World Index for Six Consecutive Years Dec. 16, 2022 Business Development of a Biodegradable/Compostable Dispersion Using BioPBS Dec. 2, 2022 Business The Mitsubishi Chemical Group launches the Composite Engineering Challenge to support startups scaling up manufacturing with lightweight composite materials Nov. 28, 2022 Business Fashion event to be held featuring the triacetate material SoalonStudents of Tokyo’s Bunka Gakuen University and Osaka’s Ueda College of Fashion will present their designs themed on “Wedding” Nov. 25, 2022 Business Commemorative Ceremony Held for Completion of the Marketing Technical Center Food Park, a Base for Providing Solutions for the Diversifying Needs of the Food Market in China Nov. 24, 2022 Business Notice on the Start of Consultation on Cessation of the Production of Methacrylates in Mitsubishi Chemical UK Limited Nov. 24, 2022 Business Delivering Design for Distinctive RadiancePlant-based Engineering Plastic DURABIO™ Adopted for Shiseido’s Global Luxury Brand ‐Clé de Peau Beauté‐ Iconic Product Nov. 24, 2022 Business GARDP and Mitsubishi Tanabe Pharma Corporation announce partnership in search for new antibiotics Nov. 9, 2022 Business RADICAVA® Oral Suspension Approved in Canada for the Treatment of ALS Nov. 8, 2022 Financial Results Notice On Revision to Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2023 Nov. 8, 2022 Financial Results Consolidated Financial Results for the First Half of the Fiscal Year Ending March 31, 2023 (Under IFRS) Oct. 18, 2022 Business Joint Development of a Sleep Sensor with Health Sensing Ability:MCG Group’s highly sensitive piezoelectric film contributes toward improving the quality of sleep Oct. 17, 2022 Business Inebilizumab has received import and marketing permission in Taiwan for Neuromyelitis Optica Spectrum Disorder Oct. 14, 2022 Business New Research Building for the Science & Innovation Center OpensTo Create Constant Innovation for Sustainable Social Contribution Oct. 5, 2022 Business The Mitsubishi Chemical Group at K 2022: Building a sustainable future together Oct. 4, 2022 Business Zeolite Membrane (ZEBREX邃｢) Dehydration System Starts Operation at US Aemetis Bioethanol Refining Plant: New dehydration system reduces energy consumption by more than 20% compared to the conventional system Oct. 3, 2022 Business The Mitsubishi Chemical Group Defers Final Investment Decision for Alpha Technology Plant in Geismar, Louisiana Sep. 30, 2022 Business Collaboration with the Japan Windsurfing Association on Carbon Fiber RecyclingConclusion of a sponsorship contract with professional windsurfer Takuma Sugi Sep. 26, 2022 Business Approval of Mounjaro, the world’s first sustained release GIP/GLP-1 receptor agonist for the treatment of type 2 diabetes in Japan Sep. 13, 2022 Others Planet Positive Chemicals Report Released from Joint Research for the Conservation of the Global Commons with the University of Tokyo Sep. 1, 2022 Business Announcement of Strategic Partnership Agreement Aimed at Achieving Carbon Neutrality in the Kashima Coastal Industrial Zone Aug. 31, 2022 Others Newsletter Vol. 1: Business Overview of the Mitsubishi Chemical GroupFocus on the Electronics and Healthcare & Life Science Market Aug. 22, 2022 Others Corporate Split in Tandem with Intergroup Organizational Restructuring Aug. 5, 2022 Business The Mitsubishi Chemical Group to Transfer API Corporation Shares Aug. 3, 2022 Financial Results Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2023 (Under IFRS) Aug. 2, 2022 Others Regarding Some News Reports Today Aug. 1, 2022 Business Plant-based bioengineering plastic "DURABIO邃｢" has been adopted for Casio "PRO TREKﾂｮ," a watch brand for nature lovers Jul. 29, 2022 Business Establishment of New Technology Study Group for Art in the IoT Era Jul. 29, 2022 Personnel Announcement of Personnel Changes of the Mitsubishi Chemical Group Jul. 28, 2022 Business The Mitsubishi Chemical Group to Boost UK Production of SoarnoL邃｢ EVOH Resin Jul. 26, 2022 Business DURABIO邃｢, a plant-based bio engineering plastic with excellent scratch resistance, has been adopted for the industry's first biomass helmet Jul. 26, 2022 Business The Mitsubishi Chemical Group Invested in Eridan, a US startup that develops Break-through Devices for 5G communications Jul. 26, 2022 Personnel Announcement of Organizational Changes and Personnel Changes of the Mitsubishi Chemical Group Jul. 21, 2022 Business Notice of Termination of the Recombinant Human Serum Albumin Business Jul. 20, 2022 Business Multilayer Films Containing the Mitsubishi Chemical Group´s SoarnoL EVOH Resins Up To 15 weight% Are Certified Recyclable Jul. 8, 2022 Business The Mitsubishi Chemical Group Discontinues Production and Sale of Some Solid Bisphenol A Epoxy Resin Products Jul. 7, 2022 Business Eli Lilly Japan and Mitsubishi Tanabe Pharma Corporation signed a sales collaboration agreement in Japan for GIP/GLP-1 receptor agonist “Tirzepatide” Jun. 30, 2022 Business Anti-cytomegalovirus chemotherapeutic agents　"Valixa® Dry Syrup 5000mg" Notification of application for additional indication of symptomatic congenital cytomegalovirus infection in Japan Jun. 29, 2022 Business Mitsubishi Chemical Holdings Group is launching a corporate partnership program "TANAMIN Digital Health Challenge - Creating hope for all facing illness" to support startup companies in the digital health field, in collaboration with Plug and Play Japan Jun. 21, 2022 Business CANAGLU® Tablets 100mg Approved for the Indication of Chronic Kidney Disease Complicated with Type 2 Diabetes Mellitus in Japan Jun. 1, 2022 Business Launch of DYSVAL® capsules 40mg for Treatment of Tardive Dyskinesia in Japan May 30, 2022 Business Resource-Recycling (Label to Label) Shrink Sleeve Label Adopted for the first time in Japan May 30, 2022 Business Enhancement of Anode Materials for the Lithium-ion Battery BusinessMitsubishi Chemical Holdings Group strengthens production capacity of low-swelling natural graphite anode materials in China and starts discussing production in the West May 23, 2022 Business Bio-based Engineering Plastic DURABIO邃｢ Adopted for the Front Grill of Suzuki S-CROSS May 19, 2022 Others Notice on Change of Trade Name and Partial Amendment to Articles of Incorporation May 19, 2022 Others Announcement Regarding Adjustment of Conversion Price for Zero Coupon Convertible Bonds due 2024 May 19, 2022 Others Notice Regarding Distribution of Dividends from Surplus May 19, 2022 Personnel Notice Regarding Executive Personnel Changes May 13, 2022 Financial Results Consolidated Financial Results for the Fiscal Year Ended March 31, 2022 (Under IFRS) May 13, 2022 Business FDA approval of RADICAVA ORS® for the treatment of ALS May 11, 2022 Business Achieving Eco-friendliness and DeliciousnessDevelopment of Barrier Packaging Material for Coffee Beans and Other Foods Using Biodegradable and Compostable Plastic BioPBS邃｢ Apr. 27, 2022 Personnel Announcement of Organizational Changes and Personnel Changes of Mitsubishi Chemical Holdings Group Apr. 27, 2022 Others Notice Regarding Disposition of Treasury Shares as Equity Compensation in the Form of Restricted Shares Apr. 25, 2022 Business Mitsubishi Chemical Holdings Group Invests in Myoridge, a Japanese Startup Offering Innovative Products and Services for the Cell Culture Market Apr. 25, 2022 Business Swissmedic has accepted the New Oral Edaravone Formulation for the treatment of ALS Apr. 19, 2022 Business European Patent Office Declares the Validity of the Mitsubishi Chemical Holdings Group's Patent for the Production and Sale of High-Quality Biomass-Based Polyester Pellets Apr. 15, 2022 Others MCHC Selected as Component for Newly Created ESG Index Apr. 11, 2022 Business Marketing Authorization Application of Pertussis, Diphtheria, Tetanus, Inactivated Polio and Hib Combined Vaccine (BK1310/MT-2355) Apr. 4, 2022 Business Long-Term Safety Profile from Phase 2b Clinical Trials of Parkinson's Disease Drug Candidate (ND0612) Presents at 2022 American Academy of Neurology Annual Meeting Apr. 1, 2022 Business Message for New Employees by Jean-Marc Gilson, CEO of Mitsubishi Chemical Holdings Group Apr. 1, 2022 Personnel Announcement of Personnel Changes of Mitsubishi Chemical Holdings Group Mar. 31, 2022 Others Notice on Absorption-type Merger of a Wholly-owned Subsidiary (Simplified Merger and Short-form Merger) Feb. 24, 2022 Business COVID-19 vaccine, “COVIFENZ® ” (MT-2766) has been approved in Canada Feb. 24, 2022 Personnel Organizational Changes and Personnel Changes of Mitsubishi Chemical Holdings Group Feb. 22, 2022 Business Diamond Edge Ventures, the Corporate Venture Capital Arm of Mitsubishi Chemical Holdings, Leads Lingrove’s Series A to Scale Production of its Carbon-Negative Ekoa®, Replacing Wood and Plastics in Furniture, Autos, and Interiors Feb. 3, 2022 Financial Results Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2022 (Under IFRS) Jan. 7, 2022 Personnel Notice Regarding Changes in Representative Corporate Executive Officers Jan. 7, 2022 Personnel Announcement of Personnel Changes Jan. 4, 2022 Business New Year Message from President and CEO, Jean-Marc Gilson Jan. 4, 2022 Personnel Personnel Changes ・Information is current as of the date of issue of the individual press release. Please be advised that information may be outdated after that point. ・Some of news releases issued by The Mitsubishi Chemical Group cover information related to pharma businesses. Disclosure of information on ethical drugs and developments is for the purpose of providing information to the press, etc., and is not for the purpose of promotion, advertising, or medical advice. Corporate Information Corporate Information Corporate Information Basic Information Message from the President Corporate Profile / Access ∟Mitsubishi Chemical Group Corporation ∟Mitsubishi Chemical Corporation ∟Mitsubishi Tanabe Pharma Corporation ∟Nippon Sanso Holdings Corporation Leadership Organization Chart Global Network Number of Subsidiaries History Corporate Brochure Evaluation by Outside Parties Approach to Corporate Activities Group Concept Charter of Corporate Behavior Value Creation Model Health and Productivity Management Management Strategy Management Policy Business Strategy ∟Specialty Materials ∟Industrial Gases ∟Health Care ∟MMA ∟Petrochemicals and Carbon Products Governance Corporate Governance ∟Corporate Governance Guidelines Risk Management Compliance Media KAITEKI Solution Center Digital Showroom Social Media ∟LinkedIn account  ∟X account  ∟YouTube channel  Business・Products Business・Products Innovation Innovation Innovation CTO Message --> Innovation Strategy Intellectual Property Strategy Mitsubishi Chemical Corporation R&D Main R&D Organization Award History Paper Submission Investor Relations Investor Relations Investor Relations Management Policy Message from the President --> Message from the CFO --> Outside Directors’ Discussion Meeting --> Management Policy Disclosure Policy IR News IR News TSE Filings Basic Information Chart IR Calendar Financial Data Evaluation by Outside Parties (ESG) Other IR Information ∟FAQ on IR ∟Contact on IR ∟IR Sitemap IR library Financial Results Operating Summaries Analysts Meeting Materials Integrated Reports Securities Reports Report in Line with the Recommendations of the TCFD To Our Individual Investors The Mitsubishi Chemical Group in Numbers Stock and Bond Information Sustainability Sustainability Sustainability Sustainability Activities Sustainability approach and promotion structure Material Issues and Sustainability(MOS) Indices ESG Initiatives Environment Society Governance Sustainability Data Sustainability (MOS) results Non-Financial Data Sheets GRI Standards KAITEKI Solution Center News Releases Information Digital Showroom Contact Us FAQ The Mitsubishi Chemical Group Official Accounts Sitemap Terms of Use Privacy Policy Social Media Terms of Use Copyright © Mitsubishi Chemical Group Corporation.